First human tests begin for new Pneumonia-Fighting vaccine
NCT ID NCT05092386
Summary
This early-stage study tested a new vaccine designed to protect against 13 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. It involved 310 healthy participants, from infants as young as 6 weeks to adults up to 49 years old. The main goal was to check the vaccine's safety and see if it triggered a protective immune response in people of different ages.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henan Center for Diseases Control and Prevention
Zhengzhou, Henan, China
Conditions
Explore the condition pages connected to this study.